Standard BioTools Inc. Disposal Group, Including Discontinued Operation, Liabilities, Current
Standard BioTools Inc. (LAB) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $0 as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2026-08-05
- 2026-06-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $0.00.
- 2026-03-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $0.00.
- 2025-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $25.63M.
- 2025-09-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $22.21M.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 |
| 2025-12-31 | $25.63M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $22.21M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $17.98M 10-Q · filed 2025-08-15 |
| 2024-12-31 | $20.80M 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |